Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PA.
Arnold AE, Brower RW, Collen D, van Es GA, Lubsen J, Serruys PW, Simoons ML, Verstraete M. Arnold AE, et al. Among authors: van es ga. J Am Coll Cardiol. 1989 Sep;14(3):581-8. doi: 10.1016/0735-1097(89)90096-x. J Am Coll Cardiol. 1989. PMID: 2504798 Free article.
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
Serruys PW, Foley DP, Jackson G, Bonnier H, Macaya C, Vrolix M, Branzi A, Shepherd J, Suryapranata H, de Feyter PJ, Melkert R, van Es GA, Pfister PJ. Serruys PW, et al. Among authors: van es ga. Eur Heart J. 1999 Jan;20(1):58-69. doi: 10.1053/euhj.1998.1150. Eur Heart J. 1999. PMID: 10075142 Free article. Clinical Trial.
Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events.
O'Neill WW, Serruys P, Knudtson M, van Es GA, Timmis GC, van der Zwaan C, Kleiman J, Gong J, Roecker EB, Dreiling R, Alexander J, Anders R. O'Neill WW, et al. Among authors: van der zwaan c, van es ga. N Engl J Med. 2000 May 4;342(18):1316-24. doi: 10.1056/NEJM200005043421803. N Engl J Med. 2000. PMID: 10793164 Free article. Clinical Trial.
Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement. Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group.
Serruys PW, de Bruyne B, Carlier S, Sousa JE, Piek J, Muramatsu T, Vrints C, Probst P, Seabra-Gomes R, Simpson I, Voudris V, Gurné O, Pijls N, Belardi J, van Es GA, Boersma E, Morel MA, van Hout B. Serruys PW, et al. Among authors: van es ga, van hout b. Circulation. 2000 Dec 12;102(24):2930-7. doi: 10.1161/01.cir.102.24.2930. Circulation. 2000. PMID: 11113042 Clinical Trial.
133 results